跳至主要内容
临床试验/NCT05043220
NCT05043220进行中(未招募)不适用

COVID-19-Prädiktoren: Klinische Studie Zur Sicherheit Von Gynäkologisch Onkologischen Patientinnen Unter Onkologischer Systemtherapie - CO-SI-ONKO-Studie

Technical University of Munich2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100
试验地点
2
主要终点
Compliance

研究概览

简要总结

We designed a monocenter prospective cohort study using PROM via app and remote monitoring via pho-toplethysmography (PPG). The application of these technologies enables an early detection of infections and therefore initiation of medical interventions. The study is conducted as feasibility analysis; primary endpoints are adherence (according to wearing time) and technical robustness.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • gynecological cancer
  • indication for systemic cancer therapy
  • patients who are legally competent and able to understand and follow instructions of the study staff
  • present informed consent

排除标准

  • no use if internet or applications
  • persons who are in a dependency or employment relationship with the study center
  • positive proof of COVID-19
  • affection of the external auditory canal

结局指标

主要结局

Compliance

时间窗: 3 months

Compliance is defined as wearing time of the in-ear-sensor.

robustness of the ppg-signal

时间窗: 3 months

number and duration of the ppg-signal transmitted

次要结局

  • number of contacts and hospitalization rates(3 months)
  • infections(3 months)
  • number of correct- and false-positive alerts(3 months)
  • OS; PFS(3 months)
  • therapy modifications(3 months)
  • effect on quality of life(3 months)
  • health-related costs(3 months)

研究者

发起方
Technical University of Munich
申办方类型
Other
责任方
Principal Investigator
主要研究者

Heike Jansen

Principal Investigator

Technical University of Munich

研究点 (2)

Loading locations...

相似试验